Report Detail
Global Antibacterial Drug Resistance Market Insights, Forecast to 2025
- RnM2359536 |
- 17 April, 2019 |
- Global |
- 148 Pages |
- QYResearch |
- Pharma & Healthcare
The global Antibacterial Drug Resistance market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antibacterial Drug Resistance market based on company, product type, end user and key regions.
This report studies the global market size of Antibacterial Drug Resistance in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antibacterial Drug Resistance in these regions.
This research report categorizes the global Antibacterial Drug Resistance market by top players/brands, region, type and end user. This report also studies the global Antibacterial Drug Resistance market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AAIPharma Services
ANTABIO
Abgentis
Abbott Laboratories
Absynth Biologics
Achaogen
Acino Holdings
Aventis Pharma
Austell Laboratories
Assembly Biosciences
Arpida
Demuris
Evolva Holding
ContraFect
Cerexa
GSK
InterMune
Isis Pharmaceuticals
Lyndra
Microbecide
Morphochem
Nabriva Therapeutics
NanoSafe Coatings
Novexel
Osel
PENDOPHARM
Pfizer
VenatoRx Pharmaceuticals
Market size by Product
Telavancin (Vibativ)
Ceftaroline Fosamil (Teflaro/ Zinforo)
Fidaxomicin (Dificid / Dificlir)
Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
Dalbavancin (Dalvance/ Xydalba)
Tedizolid Phosphate (Sivextro)
Oritavancin (Orbactiv/ Nuvocid)
Ceftolozane-Tazobactam (Zerbaxa)
Ceftazidime-Avibactam (Avycaz/ Zavicefta)
PHASE III DRUGS
Market size by End User
Gram-Positive
Gram-Negative
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Antibacterial Drug Resistance market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Antibacterial Drug Resistance market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antibacterial Drug Resistance companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antibacterial Drug Resistance submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Antibacterial Drug Resistance are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antibacterial Drug Resistance market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Antibacterial Drug Resistance Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Antibacterial Drug Resistance Market Size Growth Rate by Product
- 1.4.2 Telavancin (Vibativ)
- 1.4.3 Ceftaroline Fosamil (Teflaro/ Zinforo)
- 1.4.4 Fidaxomicin (Dificid / Dificlir)
- 1.4.5 Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
- 1.4.6 Dalbavancin (Dalvance/ Xydalba)
- 1.4.7 Tedizolid Phosphate (Sivextro)
- 1.4.8 Oritavancin (Orbactiv/ Nuvocid)
- 1.4.9 Ceftolozane-Tazobactam (Zerbaxa)
- 1.4.10 Ceftazidime-Avibactam (Avycaz/ Zavicefta)
- 1.4.11 PHASE III DRUGS
- 1.5 Market by End User
- 1.5.1 Global Antibacterial Drug Resistance Market Size Growth Rate by End User
- 1.5.2 Gram-Positive
- 1.5.3 Gram-Negative
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Antibacterial Drug Resistance Market Size
- 2.1.1 Global Antibacterial Drug Resistance Revenue 2014-2025
- 2.1.2 Global Antibacterial Drug Resistance Sales 2014-2025
- 2.2 Antibacterial Drug Resistance Growth Rate by Regions
- 2.2.1 Global Antibacterial Drug Resistance Sales by Regions
- 2.2.2 Global Antibacterial Drug Resistance Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Antibacterial Drug Resistance Sales by Manufacturers
- 3.1.1 Antibacterial Drug Resistance Sales by Manufacturers
- 3.1.2 Antibacterial Drug Resistance Sales Market Share by Manufacturers
- 3.1.3 Global Antibacterial Drug Resistance Market Concentration Ratio (CR5 and HHI)
- 3.2 Antibacterial Drug Resistance Revenue by Manufacturers
- 3.2.1 Antibacterial Drug Resistance Revenue by Manufacturers (2014-2019)
- 3.2.2 Antibacterial Drug Resistance Revenue Share by Manufacturers (2014-2019)
- 3.3 Antibacterial Drug Resistance Price by Manufacturers
- 3.4 Antibacterial Drug Resistance Manufacturing Base Distribution, Product Types
- 3.4.1 Antibacterial Drug Resistance Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Antibacterial Drug Resistance Product Type
- 3.4.3 Date of International Manufacturers Enter into Antibacterial Drug Resistance Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Antibacterial Drug Resistance Sales by Product
- 4.2 Global Antibacterial Drug Resistance Revenue by Product
- 4.3 Antibacterial Drug Resistance Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Antibacterial Drug Resistance Breakdown Data by End User
6 North America
- 6.1 North America Antibacterial Drug Resistance by Countries
- 6.1.1 North America Antibacterial Drug Resistance Sales by Countries
- 6.1.2 North America Antibacterial Drug Resistance Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Antibacterial Drug Resistance by Product
- 6.3 North America Antibacterial Drug Resistance by End User
7 Europe
- 7.1 Europe Antibacterial Drug Resistance by Countries
- 7.1.1 Europe Antibacterial Drug Resistance Sales by Countries
- 7.1.2 Europe Antibacterial Drug Resistance Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Antibacterial Drug Resistance by Product
- 7.3 Europe Antibacterial Drug Resistance by End User
8 Asia Pacific
- 8.1 Asia Pacific Antibacterial Drug Resistance by Countries
- 8.1.1 Asia Pacific Antibacterial Drug Resistance Sales by Countries
- 8.1.2 Asia Pacific Antibacterial Drug Resistance Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Antibacterial Drug Resistance by Product
- 8.3 Asia Pacific Antibacterial Drug Resistance by End User
9 Central & South America
- 9.1 Central & South America Antibacterial Drug Resistance by Countries
- 9.1.1 Central & South America Antibacterial Drug Resistance Sales by Countries
- 9.1.2 Central & South America Antibacterial Drug Resistance Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Antibacterial Drug Resistance by Product
- 9.3 Central & South America Antibacterial Drug Resistance by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Antibacterial Drug Resistance by Countries
- 10.1.1 Middle East and Africa Antibacterial Drug Resistance Sales by Countries
- 10.1.2 Middle East and Africa Antibacterial Drug Resistance Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Antibacterial Drug Resistance by Product
- 10.3 Middle East and Africa Antibacterial Drug Resistance by End User
11 Company Profiles
- 11.1 AAIPharma Services
- 11.1.1 AAIPharma Services Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AAIPharma Services Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AAIPharma Services Antibacterial Drug Resistance Products Offered
- 11.1.5 AAIPharma Services Recent Development
- 11.2 ANTABIO
- 11.2.1 ANTABIO Company Details
- 11.2.2 Company Business Overview
- 11.2.3 ANTABIO Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 ANTABIO Antibacterial Drug Resistance Products Offered
- 11.2.5 ANTABIO Recent Development
- 11.3 Abgentis
- 11.3.1 Abgentis Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Abgentis Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Abgentis Antibacterial Drug Resistance Products Offered
- 11.3.5 Abgentis Recent Development
- 11.4 Abbott Laboratories
- 11.4.1 Abbott Laboratories Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Abbott Laboratories Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Abbott Laboratories Antibacterial Drug Resistance Products Offered
- 11.4.5 Abbott Laboratories Recent Development
- 11.5 Absynth Biologics
- 11.5.1 Absynth Biologics Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Absynth Biologics Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Absynth Biologics Antibacterial Drug Resistance Products Offered
- 11.5.5 Absynth Biologics Recent Development
- 11.6 Achaogen
- 11.6.1 Achaogen Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Achaogen Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Achaogen Antibacterial Drug Resistance Products Offered
- 11.6.5 Achaogen Recent Development
- 11.7 Acino Holdings
- 11.7.1 Acino Holdings Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Acino Holdings Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Acino Holdings Antibacterial Drug Resistance Products Offered
- 11.7.5 Acino Holdings Recent Development
- 11.8 Aventis Pharma
- 11.8.1 Aventis Pharma Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Aventis Pharma Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Aventis Pharma Antibacterial Drug Resistance Products Offered
- 11.8.5 Aventis Pharma Recent Development
- 11.9 Austell Laboratories
- 11.9.1 Austell Laboratories Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Austell Laboratories Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Austell Laboratories Antibacterial Drug Resistance Products Offered
- 11.9.5 Austell Laboratories Recent Development
- 11.10 Assembly Biosciences
- 11.10.1 Assembly Biosciences Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Assembly Biosciences Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Assembly Biosciences Antibacterial Drug Resistance Products Offered
- 11.10.5 Assembly Biosciences Recent Development
- 11.11 Arpida
- 11.12 Demuris
- 11.13 Evolva Holding
- 11.14 ContraFect
- 11.15 Cerexa
- 11.16 GSK
- 11.17 InterMune
- 11.18 Isis Pharmaceuticals
- 11.19 Lyndra
- 11.20 Microbecide
- 11.21 Morphochem
- 11.22 Nabriva Therapeutics
- 11.23 NanoSafe Coatings
- 11.24 Novexel
- 11.25 Osel
- 11.26 PENDOPHARM
- 11.27 Pfizer
- 11.28 VenatoRx Pharmaceuticals
12 Future Forecast
- 12.1 Antibacterial Drug Resistance Market Forecast by Regions
- 12.1.1 Global Antibacterial Drug Resistance Sales Forecast by Regions 2019-2025
- 12.1.2 Global Antibacterial Drug Resistance Revenue Forecast by Regions 2019-2025
- 12.2 Antibacterial Drug Resistance Market Forecast by Product
- 12.2.1 Global Antibacterial Drug Resistance Sales Forecast by Product 2019-2025
- 12.2.2 Global Antibacterial Drug Resistance Revenue Forecast by Product 2019-2025
- 12.3 Antibacterial Drug Resistance Market Forecast by End User
- 12.4 North America Antibacterial Drug Resistance Forecast
- 12.5 Europe Antibacterial Drug Resistance Forecast
- 12.6 Asia Pacific Antibacterial Drug Resistance Forecast
- 12.7 Central & South America Antibacterial Drug Resistance Forecast
- 12.8 Middle East and Africa Antibacterial Drug Resistance Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Antibacterial Drug Resistance Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Antibacterial Drug Resistance . Industry analysis & Market Report on Antibacterial Drug Resistance is a syndicated market report, published as Global Antibacterial Drug Resistance Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Antibacterial Drug Resistance market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
